US FDA approvals bounce back in 2023, sparking hopes of a biotech recovery Jan 2, 2024 Posted by suite100 In People About the author ⁄ suite100 Prev Harvard president Claudine Gay resigns amid plagiarism claims, backlash from antisemitism testimony Next Short-term leases from 5 to 12 months are increasingly popular
